New Technique Harvests Stem Cells at Earlier Stage
By HealthDay News,
HealthDay News
| 07. 09. 2008
WEDNESDAY, July 9 (HealthDay News) -- Scientists say they have finally succeeded in developing human embryonic stem cells earlier in the development stage of a blastomere, or a 4-cell stage embryo, so the whole embryo is not destroyed.
The development, expected to be presented Wednesday at the European Society of Human Reproduction & Embryology annual conference in Barcelona, may make stem cell research easier to conduct by not raising as many ethical concerns, the researchers added.
"Previously, scientists have been able to derive hESC [human embryonic stem cell] lines at the 8-cell stage," Hilde Van de Velde of the Vrije Universiteit Brussel, Brussels, Belgium, said in a news release issued by the society, "but success rates were variable, and it was necessary to culture them by mixing with established hESC lines. We have been able to derive hESCs at an earlier stage of embryonic development, and without the need for co-culture with established hESC lines. Now we have derived a second hESC from one cell of a 4-cell stage embryo. Given the complex nature of earlier attempts, we were pleased...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Roni Caryn Rabin, The New York Times | 01.22.2026
The National Institutes of Health said on Thursday it is ending support for all research that makes use of human fetal tissue, eliminating funding for projects both within and outside of the agency.
A ban instituted in June 2019 by...
By David Jensen, The California Stem Cell Report | 12.11.2025
California’s stem cell and gene therapy agency today approved spending $207 million more on training and education, sidestepping the possibility of using the cash to directly support revolutionary research that has been slashed and endangered by the Trump administration.
Directors...
By Frankie Fattorini, Pharmaceutical Technology | 12.02.2025
Próspera, a charter city on Roatán island in Honduras, hosts two biotechs working to combat ageing through gene therapy, as the organisation behind the city advertises its “flexible” regulatory jurisdiction to attract more developers.
In 2021, Minicircle set up a...